Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02057172
What this trial is testing

Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hanmi Pharmaceutical Company Limited 254
Post-approval studies (Phase 4)Study completedNCT01461577
What this trial is testing

Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 89
Not applicableLooking for participantsNCT07743567
What this trial is testing

Gestational Response, Outcomes, and Weight After GLP-1 Use

Who this might be right for
Pregnant IndividualsObesity & OverweightGestational Weight Gain
University of Kansas Medical Center 400
Testing effectiveness (Phase 2)Study completedNCT00423501
What this trial is testing

A GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 306
Not applicableStudy completedNCT03680482
What this trial is testing

To Compare the Effects of Non-nutritive Sweeteners Intake in Subjects With T2DM

Who this might be right for
Diabetes Mellitus, Type 2
University of Chile 17
Post-approval studies (Phase 4)UnknownNCT05597202
What this trial is testing

Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 22
Not applicableStudy completedNCT00784745
What this trial is testing

Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect

Who this might be right for
Insulin ResistanceGlucose Intolerance
University Hospital, Gentofte, Copenhagen 21
Not applicableStudy completedNCT01153438
What this trial is testing

Relationship Between Changes in Gut Hormones After Gastric Bypass and Gastric Banding and Improvements in Diabetes

Who this might be right for
Type 2 DiabetesObesityBariatric Surgery
University of Pennsylvania 8
Not applicableStudy completedNCT07623148
What this trial is testing

GLP-1 RA Cessation and Gastric Ultrasound Findings

Who this might be right for
Residual Gastric ContentsDelayed Gastric Emptying
Wonkwang University Hospital 186
Testing effectiveness (Phase 2)Ended earlyNCT00566215
What this trial is testing

Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study

Who this might be right for
Diabetes Mellitus, Type 2Insulin ResistanceObesity
University of Campinas, Brazil 6
Post-approval studies (Phase 4)Active Not RecruitingNCT06801015
What this trial is testing

Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions

Who this might be right for
Obesity
Mayo Clinic 30
Not applicableNot Yet RecruitingNCT07687667
What this trial is testing

Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS

Who this might be right for
Polycystic Ovary Syndrome (PCOS)ObesityInfertility, Female
Peking University Third Hospital 406
Not applicableStudy completedNCT04876495
What this trial is testing

The Effects of Whey, Rice and Potato pRotein isOlates on appeTite rEgulatIoN in Healthy Men

Who this might be right for
Appetite and General Nutritional Disorders
University of Westminster 12
Not applicableStudy completedNCT01674972
What this trial is testing

Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls

Who this might be right for
Non Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis
University Hospital, Basel, Switzerland 102
Large-scale testing (Phase 3)Active Not RecruitingNCT06162715
What this trial is testing

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

Who this might be right for
Severe ObesityObesityBMI Greater Than 30
Vanderbilt University Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT07336862
What this trial is testing

Bariatric Surgery Combined With GLP-1 Receptor Agonists Study

Who this might be right for
Obesity
China-Japan Friendship Hospital 200
Not applicableLooking for participantsNCT06814080
What this trial is testing

Residual Gastric Content and GLP-1

Who this might be right for
Pre-op Gastric Emptying
University of Arkansas 45
Not applicableStudy completedNCT02598791
What this trial is testing

GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake

Who this might be right for
ObesityAdiposityType 2 Diabetes
University Hospital, Gentofte, Copenhagen 18
Testing effectiveness (Phase 2)UnknownNCT01845259
What this trial is testing

Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?

Who this might be right for
Impaired Glucose Tolerance Associated With Drugs
Psychiatric Centre Rigshospitalet 103
Large-scale testing (Phase 3)Study completedNCT01189890
What this trial is testing

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 480
Next Page